Pregabalin Completed Phase 4 Trials for Diabetic Neuropathy, Painful Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00156078A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)
NCT00159679Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy
NCT00385671An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain